2022
DOI: 10.1002/ehf2.13980
|View full text |Cite
|
Sign up to set email alerts
|

Combined mechanical circulatory support for ventricular fibrillation in left ventricular assist device patient

Abstract: Ventricular fibrillation, a life‐threatening ventricular arrhythmia, may result in pulselessness, loss of consciousness and sudden cardiac death. In this case report, we describe our experience in managing a 54‐year‐old man with HeartMate3 left ventricular assist device (LVAD) as a bridge to transplantation due to dilated non‐ischemic cardiomyopathy, presenting with incessant ventricular arrhythmia for 35 days despite multiple attempts to restore normal rhythm with external direct current cardioversion and ant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 9 publications
(12 reference statements)
0
3
0
Order By: Relevance
“…In instances of RV dysfunction or hemodynamic collapse, prompt hemodynamic support is imperative to prevent irreversible end-organ damage. There is a parallel case [ 7 ] involving a 54-year-old patient with dilated non-ischemic cardiomyopathy, sustained by LVAD (HeartMate3) as a bridging strategy for transplantation. This patient remained stable for 35 days, experiencing persistent VAs and RV failure, managed concomitantly with VA-ECMO and LVAD, culminating in heart transplantation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In instances of RV dysfunction or hemodynamic collapse, prompt hemodynamic support is imperative to prevent irreversible end-organ damage. There is a parallel case [ 7 ] involving a 54-year-old patient with dilated non-ischemic cardiomyopathy, sustained by LVAD (HeartMate3) as a bridging strategy for transplantation. This patient remained stable for 35 days, experiencing persistent VAs and RV failure, managed concomitantly with VA-ECMO and LVAD, culminating in heart transplantation.…”
Section: Discussionmentioning
confidence: 99%
“…The current literature reports that incidence of VAs after LVAD implantation ranges from 28–49% [ 4 6 ]. Ventricular arrhythmias can be well-tolerated with LVAD but if persistent, they may lead to haemodynamic compromise, right ventricular (RV) failure, and secondary organ dysfunctio [ 7 , 8 ]. The management of ventricular arrhythmias in LVAD patients remains challenging and requires close collaboration of heart failure cardiologists, arrhythmiologists, and heart transplant surgeons.…”
Section: Introductionmentioning
confidence: 99%
“…The LVAD effectively provided support for 60 min during VF with sinus rhythm; however, it was noted that AF was unable to sustain both systemic and pulmonary circulation in the presence of elevated central venous pressure [21]. This result may, in part, be influenced by right ventricular failure associated with AF; nonetheless, it underscores the significance of maintaining sinus atrial rhythm in such a specific scenario [16,22]. Further studies are warranted to better clarify the clinical implication of the presence of AF during durable LVAD supports.…”
Section: Atrial Arrhythmiasmentioning
confidence: 99%
“…The current literature reports that incidence of VAs after LVAD implantation ranges from 28-49% [4][5][6] . Ventricular arrhythmias can be well-tolerated with LVAD but if persistent, they may lead to haemodynamic compromise, right ventricular (RV) failure, and secondary organ dysfunctio 7,8 . The management of ventricular arrhythmias in LVAD patients remains challenging and requires close collaboration of heart failure cardiologists, arrhythmiologists, and heart transplant surgeons.…”
Section: Introductionmentioning
confidence: 99%